Step by Step


9/15/2020 - Medical Grand Rounds: Reasons for Facial Masking for COVID-19: Transmission, Severity of Disease and Immunity





Credit Hours: CME 1.00

Target Audience:

Faculty, residents, fellows, and community physicians in General Internal Medicine and subspecialties.

Educational Objectives:

Upon completion of this activity, participants should be able to:

  • Evaluate the data on how facial masking reduces transmission of COVID-19 to both the wearer and to others
  • Describe how facial masking decreases the severity of disease with COVID-19 via the viral inoculum theory
  • Review immunity to SARS-CoV-2 with mild/asymptomatic infection
  • Examine updates on UPMC Senior Communities COVID-19 experience​
  • Examine updates on the Regional Response Health Collaborative Program​
  • Review challenges with testing requirements​
  • Review updates from the White House Commission

Suggested Additional Reading & Joint Accreditation Statement::

  1. Gandhi M, Rutherford G. Facial Masking for Covid-19 — Potential for “Variolation” as We Await a Vaccine. NEJM September 2020. DOI: 10.1056/NEJMp2026913
  2. Gandhi M, Beyrer C, Goosby E. Masks Do More than Protect Others during COVID-19: Reducing the Inoculum of SARS-CoV-2. Journal of General Internal Medicine 2020 
  3. Professional and home-made face masks reduce exposure to respiratory infections among the general population.
  4. van der Sande M, Teunis P, Sabel R.
  5. PLoS One. 2008 Jul 9;3(7):e2618. doi: 10.1371/journal.pone.0002618

    Joint Accreditation Statement: This statement supersedes all other accreditation statements on this page.

    In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    The University of Pittsburgh School of Medicine is accredited by the ACCME to provide continuing medical education for physicians. The University of Pittsburgh School of Medicine designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Each physician should only claim credit commensurate with the extent of their participation in the activity.

    Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.

Bryan McVerry, MD — Associate Professor of Medicine, Environmental and Occupational Health, Clinical and Translational Science. Division of Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh
Dr. McVerry receives grant and research support from Bayer Pharmaceuticals, Inc
David A. Nace, MD, MPH — Associate Professor of Medicine, Director of Long Term Care & Flu Programs / University of Pittsburgh, Institute on Aging, Medical Director
No relationships with industry relevant to the content of this educational activity have been disclosed.
Monica Gandhi, MD, MPH — Professor of Medicine and Associate Chief in the Division of HIV, Infectious Diseases, and Global Medicine at the University of California, San Francisco (UCSF)
No relationships with industry relevant to the content of this educational activity have been disclosed.
No other members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships with any companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

This activity is approved for AMA PRA Category 1 Credit™

The University of Pittsburgh is an affirmative action, equal opportunity institution.